NASDAQ

Novanta Inc. - Common Shares (NOVT)

720 Thanks from members

Novanta Inc. (NOVT) demonstrates solid Q2 2026 performance with 10% GAAP revenue growth, strong organic expansion, and expanded adjusted EBITDA margins, though investors monitor capital allocation strategies like its shelf offering and integration risks from the Riverpoint acquisition.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →